Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Best Practice and Research: Clinical Haematology is Scopus-indexed (Q2, CiteScore 4.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bailliere Tindall Ltd.
Checked against the index lists dated .
ISSN 1521-6926Verify ISSN ↗1532-1924Verify ISSN ↗
Publisher: Bailliere Tindall Ltd
Cost to publish: About US$3,730 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 171 / 428 | 60th | Q2 |
| Clinical Biochemistry | 57 / 124 | 54th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1999–2025, best quartile Q2, CiteScore 4.8.
Best Practice and Research: Clinical Haematology is Q2 in Oncology (rank 171 of 428) and Q2 in Clinical Biochemistry (rank 57 of 124), by CiteScore 2025.
Best Practice and Research: Clinical Haematology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.8, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.945, quartile Q2, with an H-index of 84.
The publisher lists an article processing charge of about US$3,730 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Best Practice and Research: Clinical Haematology is published by Bailliere Tindall Ltd. Its print ISSN is 1521-6926 and its online ISSN is 1532-1924.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Best Practice and Research: Clinical Haematology has an h-index of 88 and a 2-year mean of 4.5 citations per paper (OpenAlex). Its Scopus CiteScore is 4.8, quartile Q2. On 2-year citations it ranks #69 of 424 Scopus journals in Oncology.
Best Practice and Research: Clinical Haematology published 31 papers in 2025; its busiest recent year was 2016 with 70. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2023–2025), authors are most often from United States (55.6%), Germany (13.9%) and United Kingdom (5.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.